Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies
Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page
- ChecktodayChange DetectedRecruitment is closed for this study, and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, while the Intervention/Treatment header formatting and the revision label were updated to v3.6.0.SummaryDifference0.2%

- Check8 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4. This reflects a behind-the-scenes update to the page's build or rendering.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe revision indicator on the page was updated from v3.5.3 to v3.5.4, indicating a newer version of the page's revision or template.SummaryDifference0.0%

- Check51 days agoChange DetectedThe site’s page revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor platform/content-system update rather than a change to the underlying trial information.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the site metadata.SummaryDifference0.0%

- Check87 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.